February 24, 2026 · Form 4 insider transaction
NEWHALL CHARLES W III sold 4,475 shares of Supernus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 1 day after the transaction.
Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.; These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026.